Edwin Collier, TransForm Pharmaceuticals, Inc., Lexington, MA
The importance of detailed crystal form screening and analysis will be addressed, with emphasis placed on how an increased knowledge of form diversity aids in the selection of a suitable candidate for further development. The application of high-throughput technology to maximize the screening effort, along with thorough laboratory characterization and form comparison, will be highlighted using case studies of both pharmaceutical salt and co-crystals systems.
Back to Molecular Solids: Functional Materials and Polymorphism - Session 2
Back to The 34th Northeast Regional Meeting (October 5-7 2006)